Mesenchymal Stem Cell Therapies for ALS
Time & Location
About the Event
We are excited to host EverythingALS Community Event: Mesenchymal Stem Cell Therapies for ALS.
We invite you to join us and other people with ALS and families to engage in a positive setting of collaboration and community.
The meeting will be on Wednesday, March 10th 2021 at 4:00 pm PT
-5:00pm Mountain Time
-6:00pm Central Time
-7:00pm Eastern Time
The meeting will be approximately 45-60mins long followed by an open forum.
Once you RSVP the Zoom details with password will be sent via email. Watch out for the email.
If you have any questions please email us at email@example.com.
Our speaker, Dr. Nathan Staff from Mayo Clinic, will discuss Mesenchymal Stem Cell Therapies for ALS.
Dr. Staff is a neurologist at Mayo Clinic in Rochester, Minnesota, and an associate professor of neurology at the Mayo Clinic College of Medicine and Science. His research focus is to discover new treatments or prevent peripheral nervous system damage that occurs after surgery, from chemotherapy and ALS. Dr. Staff's Translational Neuromuscular Disease Research Lab helps accomplish the development of treatments in the laboratory setting and then apply them in clinical trials.
Dr. Staff's research team has led studies focused on mesenchymal stem cells (MSCs) in amyotrophic lateral sclerosis (ALS), having completed a Phase I first-in-human study and launched a Phase II study using these cells. Active clinical trials for the Translational Neuromuscular Disease Research Lab include:
- Intrathecal Autologous Adipose-Derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)
- Safety and Efficacy of Repeated Administration of NurOwn in ALS Patients
- Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
We look forward to seeing you at the event!